This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
BC200-Driven Translational Regulation as a Therapeutic Target and Biomarker in Tubo-Ovarian High-Grade Serous Carcinoma
Electrochemical Quantification of Chemotherapy Resistance
Delving deeper into chaos of ovarian cancer genomes—from telomere-to-telomere
Testing the in vitro mechanism and in vivo efficacy of an experimental drug to kill epithelial ovarian cancer
Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer
Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment
Uncovering targetable interactions of ovarian cancer cells
Uncovering novel metabolic regulators of T cell function
Exploring the role of PARG in DNA repair and cancer
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
